ClinicalTrials.Veeva

Menu

Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI) (STEMI-Plastics)

S

Sant'Andrea University Hospital

Status

Enrolling

Conditions

ST-elevation Myocardial Infarction (STEMI)
Microplastics
Nanoplastics
Pollution Exposure

Study type

Observational

Funder types

Other

Identifiers

NCT06965023
0379/2025

Details and patient eligibility

About

Air pollution and microplastics pose major public health threats. Emerging data have shown that micro- and nanoplastics (MNPs) are ubiquitous environmental pollutants accumulating in human tissues, triggering inflammation and prothrombotic state. This study will investigate the presence and burden of MNPs within coronary thrombi/thromboaspirate of patients presenting with ST segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention and their association with cardiac damage, plaque vulnerability, microvascular obstruction, and cardiovascular events. Plaque vulnerability will be explored by optical coherence tomography, while microvascular obstruction will be assessed by bolus thermodilution and cardiac magnetic resonance. Participants will be followed up for 1-year to evaluate whether the presence and the burden of MNPs will be associated with a higher incidence of the cardiovascular events.

Enrollment

130 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All the following inclusion criteria should be fulfilled:

  1. Age > 18 years old;
  2. STEMI undergoing urgent invasive coronary angiography;
  3. Acute thrombotic coronary occlusion/sub-occlusion (TIMI 0/1);
  4. Clinical indication to thromboaspiration;
  5. Able to give informed consent.

Exclusion criteria

  1. Contraindications to percutaneous coronary intervention;
  2. Hemodynamic instability or cardiogenic shock;
  3. End-stage chronic kidney disease;
  4. Life expectancy < 1 year due to non-cardiac pathology.

Trial design

130 participants in 2 patient groups

STEMI patients with presence of micro- and nano-plastics (MNPs).
Description:
Consecutive patients with ST-elevation myocardial infarction (STEMI) undergoing urgent invasive coronary angiography with evidence of acute thrombotic coronary occlusion/sub-occlusion and clinical indication to thromboaspiration with the presence of micro- and nano-plastics (MNPs).
STEMI patients without presence of micro- and nano-plastics (MNPs)
Description:
Consecutive patients with ST-elevation myocardial infarction (STEMI) undergoing urgent invasive coronary angiography with evidence of acute thrombotic coronary occlusion/sub-occlusion and clinical indication to thromboaspiration without the presence of micro- and nano-plastics (MNPs).

Trial contacts and locations

10

Loading...

Central trial contact

Clinical Research Unit Cardiology Dept. Sant'Andrea University Hospital; Emanuele Barbato, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems